scispace - formally typeset
Journal ArticleDOI

Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis

TLDR
The revised criteria facilitate the diagnosis of MS in patients with a variety of presentations, including “monosymptomatic” disease suggestive of MS, disease with a typical relapsing‐remitting course, and disease with insidious progression, without clear attacks and remissions.
Citations
More filters
Journal ArticleDOI

Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.

TL;DR: The character of MAIT cells in the peripheral blood of MS patients was analyzed and they showed a suppressive activity against IFN-γ production by T cells in vitro, suggesting an immune-regulatory role of MAit cells in MS through suppression of pathogenic T(h)1 cells.
Journal ArticleDOI

The predictive value of gray matter atrophy in clinically isolated syndromes.

TL;DR: Selective GM atrophy is relevant in patients with CIS who convert early to MS and the inclusion of GM analysis in the MS diagnostic workup is worthy of further investigation.
Journal ArticleDOI

MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.

TL;DR: Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS and the ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS.
Journal ArticleDOI

Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study

TL;DR: A 7-year shorter life expectancy and almost threefold higher mortality in MS compared with the general population is found and a rise in survival in MS was observed during the entire observation period.
Journal ArticleDOI

Clinical Stabilization and Effective B-Lymphocyte Depletion in the Cerebrospinal Fluid and Peripheral Blood of a Patient With Fulminant Relapsing-Remitting Multiple Sclerosis

TL;DR: Beneficial clinical effects of rituximab in relapsing-remitting MS, mediated through modulation of humoral systemic and central nervous system intrinsic immune responses, are demonstrated.
References
More filters
Journal ArticleDOI

The clinical course of neuromyelitis optica (Devic's syndrome)

TL;DR: Clinical, laboratory, and imaging features generally distinguish neuromyelitis optica from MS, and patients with relapsing optic neuritis and myelitis may have neuromyeliitis opticas rather than MS.
Journal ArticleDOI

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

TL;DR: It is concluded that a four-parameter dichotomized MRI model including gadolinium-enhancement, juxtacortical, infratentorial and periventricular lesions best predicts conversion to clinically definite multiple sclerosis.
Journal ArticleDOI

MRI in the diagnosis of MS A prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT

TL;DR: MRI was the best method for demonstrating dissemination in space and laboratory-supported definite MS (LSDMS) could be diagnosed in 85 patients of the total 200, and MRI predicted that diagnosis in 18/19 (95%).
Related Papers (5)